Paper icon

Minimizing Risk in API & Drug Product Development & Manufacturing

Benefits of a Full-Service, Single-Provider CDMO Model in a Global Market

Please complete the form to download the whitepaper.

*

*

*

*

*

*

*

*

Overview

Cell Culture Basics HandBook

The pharmaceutical and biopharma industry continues to experience solid growth in an expanding global market. This market growth has been accompanied by an ever-changing industry landscape, with consolidation among long-time "big pharma" leaders, ongoing mergers and acquisitions, and the emergence of start-ups and technology-based offshoots from academic laboratories. As the industry continuously adapts to evolving market pressures -- whether medical, economic, or demographic in nature -- the trend toward outsourcing of Active Pharmaceutical Ingredient (API) & Drug Product (DP) manufacturing to (Contract Manufacturing Organizations) CMOs with specialized capabilities, expertise and infrastructure remains a strong one.

Key Learning Objectives

  • Understand the challenges faced by the biopharma and pharmaceutical industry
  • Learn the needs faced in peptides, lipids, carbohydrates & oligonucleotides, highly potent & oncology, injectables, small molecules and antibiotic market sectors
  • Understand the advantages of having a fully-integrated global supply chain partner
  • Learn the value of having CordenPharma as your CDMO: Greater security, quality compliance, and time & cost efficiency